Efficacy of acarbose in Chinese subjects with impaired glucose tolerance
- 1 September 2003
- journal article
- research article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 61 (3), 183-190
- https://doi.org/10.1016/s0168-8227(03)00117-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminThe New England Journal of Medicine, 2002
- Glucose Tolerance and Cardiovascular MortalityArchives of Internal Medicine, 2001
- Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitusDiabetic Medicine, 2000
- Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological dataBMJ, 1998
- Impaired glucose tolerance: what are the clinical implications?Diabetes Research and Clinical Practice, 1998
- An Asian Multicenter Clinical Trial to Assess the Efficacy and Tolerability of Acarbose Compared With Placebo in Type 2 Diabetic Patients Previously Treated With DietDiabetes Care, 1998
- The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose ToleranceDiabetes Care, 1996
- An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDMDiabetes Care, 1996
- Impaired Glucose Tolerance and its Relationship to ECG-Indicated Coronary Heart Disease and Risk Factors Among Chinese: Da Qing IGT and diabetes studyDiabetes Care, 1993